Collective vs Hers: Which GLP-1 Provider Is Better?
Short answer: Hers scores higher on our rubric, 5.3/10 against 4.6/10. Full reasoning, pricing and the cases where the other one wins are below.
Hers beats Collective overall, scoring 5.3/10 vs 4.6/10. Published pricing is not a like-for-like monthly comparison: Collective is from $59/mo; Hers is $188 first month, then $298/mo. Choose Collective for cash-pay patients planning to stay in treatment long enough for the low flat medication rate to offset the required annual membership. Choose Hers for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path.
A side-by-side look at Collective and Hers to help you decide. We compare them on:
- •Starting price and billing period
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Collective
#32 of 36CollectiveOS is a membership telehealth platform operated by Health For Everyone Inc. It advertises compounded semaglutide at $59 a month and compounded tirzepatide at $69 a month, with the same medication price at every dose and no multi-month medication commitment. The required membership is free for 21 days and then costs $199 a year. That makes the first-year cash totals $907 for semaglutide and $1,027 for tirzepatide before any technology transaction fee that the terms permit but do not price. Membership includes clinician review, unlimited doctor messaging, nutrition and lifestyle support, and two-day express cold shipping. Collective links to LegitScript's public checker and identifies MDIntegrations as an example clinician network, but it does not publicly name a dispensing pharmacy or list the states it serves.
Visit CollectiveHers
#26 of 36The women's health arm of Hims & Hers Health (NYSE: HIMS). Hers lists Wegovy pill, Foundayo, and Ozempic pill medication from $149, a Wegovy pen from $199, Zepbound from $299, and compounded options. Wegovy and Foundayo carry FDA approval for weight management. Ozempic is FDA approved for type 2 diabetes and is prescribed off label for weight loss. A required Weight Loss Membership adds $39 in month one and $149/mo thereafter, so the all-in floor for a $149 medication path is $188 initially and $298/mo ongoing; exact product and dose prices vary.
Visit Hers| Feature | Collective | Hers |
|---|---|---|
| Why each one | Very low month-to-month medication pricing that remains flat across doses, funded through a separately disclosed annual membership. | A major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options. |
| Our Score | 4.6/10 | 5.3/10 |
| Headline Price | from $59/mo | $188 first month, then $298/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | Cash-pay. Collective says medication and membership are HSA/FSA eligible; eligibility and reimbursement depend on the account and expense. | No |
| Best For | Cash-pay patients planning to stay in treatment long enough for the low flat medication rate to offset the required annual membership | Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path |
| Watch out for | The $59 and $69 medication headlines exclude a required $199 annual membership after a 21-day trial | Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03). |
| Ranking | #32 | #26 |
| Get started | Visit Collective | Visit Hers |
Pros & Cons Compared
Collective
Pros
- +$59/mo compounded semaglutide and $69/mo compounded tirzepatide, with the medication price advertised as flat at every dose
- +Medication is billed month to month rather than through a required multi-month medication prepayment
- +Two-day express cold shipping, clinician review, unlimited doctor messaging, and nutrition and lifestyle support are included
- +The public site links certificate 50716874 to LegitScript's verification checker
- +The legal entity and MDIntegrations clinician-network relationship are disclosed in the legal pages
Cons
- −The $59 and $69 medication headlines exclude a required $199 annual membership after a 21-day trial
- −The terms permit a nominal technology transaction fee for each electronic prescription but publish no amount
- −No dispensing pharmacy, individual clinician, medical director, or public state-availability list is named
- −The annual membership auto-renews and is generally non-refundable, with no partial-period refunds
- −Only 9 Trustpilot reviews at 4.1/5 when checked September 15, 2026, too few for a mature reputation signal
- −Cash-pay compounded medications only; no brand-name Wegovy or Zepbound and no insurance or prior-authorization service
Hers
Pros
- +Brand-name paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199. Wegovy and Foundayo carry FDA approval for weight management, Ozempic is approved for type 2 diabetes and is used off label here. With the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03).
- −Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher
Our Verdict
Hers edges out Collective with a score of 5.3/10 vs 4.6/10. Published pricing is not a like-for-like monthly comparison: Collective is from $59/mo; Hers is $188 first month, then $298/mo. Hers offers both brand-name and compounded medications, giving you more flexibility.
Reviews and pricing sources
Related comparisons
More head-to-head comparisons involving Collective and Hers.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare Collective and Wellorithmfrom $147/mo
- Compare Collective and MEDGmfrom $169/mo
- Compare Collective and Luvo Healthfrom $249/4 weeks
- Compare Hers and DudeMedsfrom $149/mo
- Compare Hers and Shedfrom $159/mo
- Compare Hers and AgelessRxfrom $199/mo + $50/mo clinical oversight
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Collective legit and is Hers legit, with the verification evidence behind each answer.
Our pick of these two: Hers · 5.3/10